Arbaclofen placarbil

Arbaclofen placarbil
Clinical data
  • N/A
ATC code none
Legal status
Legal status
  • Development terminated
CAS Number 847353-30-4
PubChem (CID) 11281011
ChemSpider 9456008
KEGG D08861 YesY
Chemical and physical data
Formula C19H26ClNO6
Molar mass 399.86 g/mol
3D model (Jmol) Interactive image

Arbaclofen placarbil (ar-BAC-loe-fen pla-KAR-bil, also known as XP19986) is a prodrug of R-baclofen. Arbaclofen placarbil possesses more favorable pharmacokinetic profile than baclofen, with less fluctuations in plasma drug levels. It was being developed as a potential treatment for patients with GERD and spasticity due to multiple sclerosis; however, in May 2013 XenoPort announced the termination of development because of unsuccessful results in phase III clinical trials.[1]

See also


This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.